Business
– Relations between Teva and Biotec have deteriorated into a legal dispute and an entanglement with the Russian authorities. – After years of...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Copaxone"
StartUps
Israeli biomed firm Mapi Pharma Ltd., which is a development stage pharmaceutical company, announced that the first patient was treated in the company’s Phase...
Business
– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target...
Business
– Generic competition for Copaxone and foreign currency volatility will hit Teva’s sales. – When Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA)...
Business
– The decision gives Teva more time to transfer patients to its better patent protected double dosage Copaxone. – Teva Pharmaceutical Industries Ltd. (NYSE:...
Business
Teva’s Copaxone, a new medication under development for the treatment of multiple sclerosis treatment Copaxone, has gotten closer to getting approval for marketing in...
Business
– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for...
Business
– A 50% reduction in adverse side-effects was reported with the three-times-a-week 40 mg MS injection. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
Business
– Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. – In the absence of...
Business
– Multiple sclerosis treatment Copaxone accounts for an estimated half of Teva’s profit. – Changes in the multiple sclerosis treatment market, in which...